JBIO
Jade Biosciences
JBIO
JBIO
59 hedge funds and large institutions have $488M invested in Jade Biosciences in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 23 increasing their positions, 13 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
8% less funds holding
Funds holding: 64 → 59 (-5)
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Holders
59
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$20.5M | |
| 2 | +$19.2M | |
| 3 | +$11.3M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$5.01M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$3.03M |
Top Sellers
| 1 | -$16.8M | |
| 2 | -$3.94M | |
| 3 | -$1.39M | |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$798K |
| 5 |
FAM
Fred Alger Management
New York
|
-$792K |